title: Placenta accreta and the developing world--a review.
abstract: BACKGROUND
  The rising Caesarean section rate in the developing world implies that the incidence of placenta accreta might be on the increase and this might worsen the maternal mortality burden.
  
  
  OBJECTIVE
  To draw the attention of Obstetricians and other relevant professionals to this emerging but challenging trend.
  
  
  METHODS
  Original research findings and reviews published in the English literature. Additional information was obtained from texts and electronic books such as CD ROMS.
  
  
  METHODS
  Online searches of electronic database (Medline, Pubmed and Embase), requests for reprints from corresponding authors and institutional/private subscriptions.
  
  
  RESULTS
  Information obtained was categorised accordingly.
  
  
  CONCLUSIONS
  Optimal treatment of women with placenta accreta requires recognition of the clinical risk factors, accurate pre-operative diagnosis and meticulous planning to ensure safety at the time of delivery. In view of the rising incidence of this condition, and the absence of a highly reliable antenatal diagnostic method especially in developing countries, a high index of suspicion and advanced preparation is required to reduce its associated maternal morbidity and mortality.
authors: Department of Obstetrics and Gynaecology, Nigerian Christian Hospital, P. M. B. 823 Aba, Abia State, Nigeria.
authors: C C
authors: CC
authors: Umezurike
authors: P A
authors: PA
authors: Feyi-Waboso
mesh_terms: D003906:Developing Countries; D005260:Female; D006801:Humans; D007044:Hysterectomy; D015994:Incidence; D010921:Placenta Accreta / Q000175:diagnosis* / Q000453:epidemiology / Q000209:etiology / Q000628:therapy*; D011247:Pregnancy; D011296:Prenatal Diagnosis; D012307:Risk Factors; D014662:Vasoconstrictor Agents / Q000627:therapeutic use; D014667:Vasopressins / Q000627:therapeutic use
chemical_list: D014662:Vasoconstrictor Agents; D014667:Vasopressins